Researchers have achieved a significant breakthrough in treating pancreatic cancer, with a new drug combination completely eradicating tumors in mice without major side effects. This promising development, detailed in PNAS, offers hope for improving the survival rates of this deadly disease, which is often diagnosed late due to its subtle symptoms.
